Although evidence is still lacking to support of cannabinoids as a disease-modifying therapeutic intervention, Δ9-THC exhibits improved ALS symptoms using SOD-1 mutant mice, described that Sativex affords protection of motor neurons but fails to defend neuron–muscle joint without any noticeable improvement in animal survival time [470]. Here, SOD1 is linked to amyotrophic lateral sclerosis.